In Very High-Risk Patients with Vascular Disease, Evolocumab Slightly Reduces Nonfatal MI But Not Mortality

Mark H. Ebell

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'In Very High-Risk Patients with Vascular Disease, Evolocumab Slightly Reduces Nonfatal MI But Not Mortality'. Together they form a unique fingerprint.